AA
NUVB icon

AlphaCentric Advisors’s Nuvation Bio NUVB Stock Holding History

AlphaCentric Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-135,000
Closed -$309K – 263
2024
Q3 		$309K Hold
135,000
– – 0.23% 108
2024
Q2 		$394K Hold
135,000
– – 0.29% 87
2024
Q1 		$491K Sell
135,000
-315,000
-70% -$605K 0.3% 87
2023
Q4 		$680K Buy
450,000
+40,000
+10% +$51.5K 0.46% 65
2023
Q3 		$549K Buy
410,000
+65,000
+19% +$108K 0.31% 86
2023
Q2 		$621K Hold
345,000
– – 0.34% 89
2023
Q1 		$573K Buy
345,000
+20,000
+6% +$40.5K 0.4% 80
2022
Q4 		$624K Buy
325,000
+110,000
+51% +$223K 0.62% 61
2022
Q3 		$482K Buy
+215,000
New +$614K 0.49% 56

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return